問卷

TPIDB > Search Result

Search Result

篩選

List

2394Cases

2025-11-01 - 2027-04-01

Phase I/II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2024-10-01 - 2026-12-31

Phase I/II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2025-03-01 - 2027-02-28

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2022-02-01 - 2025-01-27

Phase I/II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Not yet recruiting5Sites

2016-10-01 - 2025-12-31

Others

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites

2025-01-01 - 2031-06-30

Phase III

Active
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study of Vorasidenib (S095032/AG-881) in Asian Participants with Residual or Recurrent Grade 2 Glioma with an IDH1 or IDH2 Mutation
  • Condition/Disease

    Residual or Recurrent Grade 2 IDH Mutant Glioma

  • Test Drug

    Vorasidenib

Participate Sites
2Sites

Recruiting2Sites

2020-12-31 - 2025-12-31

Others

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2024-12-01 - 2027-06-30

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2025-01-01 - 2031-06-30

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Not yet recruiting1Sites

Recruiting1Sites

2021-08-01 - 2023-07-31

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites